New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer

被引:12
|
作者
Chiaradonna, Ferdinando [1 ,2 ]
Cirulli, Claudia [1 ,2 ]
Palorini, Roberta [1 ,2 ]
Votta, Giuseppina [1 ,2 ]
Alberghina, Lilia [1 ,2 ]
机构
[1] SYSBIO Ctr Syst Biol, Milan, Italy
[2] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy
关键词
TRANSCRIPTION FACTOR YY1; DEPENDENT PROTEIN-KINASE; ACUTE MYELOID-LEUKEMIA; YIN YANG 1; C-MYC; TUMOR-SUPPRESSOR; LYSINE ACETYLATION; PYRUVATE-KINASE; SKELETAL-MUSCLE; GENE-EXPRESSION;
D O I
10.1089/ars.2014.5854
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Histone deacetylases (HDACs) activity and cell metabolism are considered important targets for cancer therapy, as both are deregulated and associated with the onset and maintenance of tumors. Recent Advances: Besides the classical function of HDACs as HDAC enzymes controlling the transcription, it is becoming increasingly evident that these proteins are involved in the regulation of several other cellular processes by their ability to deacetylate hundreds of proteins with different functions in both the cytoplasm and the nucleus. Importantly, recent high-throughput studies have identified as important target proteins several enzymes involved in different metabolic pathways. Conversely, it has been also shown that metabolic intermediates may control HDACs activity. Consequently, the acetylation/deacetylation of metabolic enzymes and the ability of metabolic intermediates to modulate HDACs may represent a cross-talk connecting cell metabolism, transcription, and other HDACs-controlled processes in physiological and pathological conditions. Critical Issues: Since metabolic alterations and HDACs deregulation are important cancer hallmarks, disclosing connections among them may improve our understanding on cancer mechanisms and reveal novel therapeutic protocols against this disease. Future Directions: High-throughput metabolic studies performed by using more sophisticated technologies applied to the available models of conditional deletion of HDACs in cell lines or in mice will fill the gap in the current understanding and open directions for future research. Antioxid. Redox Signal. 23, 30-50.
引用
收藏
页码:30 / 50
页数:21
相关论文
共 50 条
  • [21] Linking epigenetics to lipid metabolism: Focus on histone deacetylases
    Ferrari, Alessandra
    Fiorino, Erika
    Giudici, Marco
    Gilardi, Federica
    Galmozzi, Andrea
    Mitro, Nico
    Cermenati, Gaia
    Godio, Cristina
    Caruso, Donatella
    De Fabiani, Emma
    Crestani, Maurizio
    MOLECULAR MEMBRANE BIOLOGY, 2012, 29 (07) : 257 - 266
  • [22] Molecular insights into azumamide E histone deacetylases inhibitory activity
    Maulucci, Nakia
    Chini, Maria Giovanna
    Di Micco, Simone
    Izzo, Irene
    Cafaro, Emiddio
    Russo, Adele
    Gallinari, Paola
    Paolini, Chantal
    Nardi, Maria Chiara
    Casapullo, Agostino
    Riccio, Raffaele
    Bifulco, Giuseppe
    De Riccardis, Francesco
    Journal of the American Chemical Society, 2007, 129 (10): : 3007 - 3012
  • [23] The role of histone deacetylases (HDACs) in human cancer
    Ropero, Santiago
    Esteller, Manel
    MOLECULAR ONCOLOGY, 2007, 1 (01) : 19 - 25
  • [24] The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
    Li, Guo
    Tian, Yuan
    Zhu, Wei-Guo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [25] Histone deacetylases and estrogen signalling in breast cancer
    Boulle, Nathalie
    Linares, Aurelien
    Lapierre, Marion
    Cavailles, Vincent
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2011, 15 (08): : 284 - 287
  • [26] Histone deacetylases: target enzymes for cancer therapy
    Denis Mottet
    Vincent Castronovo
    Clinical & Experimental Metastasis, 2008, 25 : 183 - 189
  • [27] Histone deacetylases: target enzymes for cancer therapy
    Mottet, Denis
    Castronovo, Vincent
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (02) : 183 - 189
  • [28] Histone deacetylases and cardiovascular cell lineage commitment
    Yang, Jun-Yao
    Wang, Qian
    Wang, Wen
    Zeng, Ling-Fang
    WORLD JOURNAL OF STEM CELLS, 2015, 7 (05): : 852 - 858
  • [29] Novel Structural Insights into Class I and II Histone Deacetylases
    Ficner, Ralf
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (03) : 235 - 240
  • [30] Molecular insights into azumamide E histone deacetylases inhibitory activity
    Maulucci, Nakia
    Chini, Maria Giovanna
    Di Micco, Simone
    Izzo, Irene
    Cafaro, Emiddio
    Russo, Adele
    Gallinari, Paola
    Paolini, Chantal
    Nardi, Maria Chiara
    Casapullo, Agostino
    Riccio, Raffaele
    Bifulco, Giuseppe
    De Riccardis, Francesco
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (10) : 3007 - 3012